Drug intelligence / Profile preview

Tangzu Fang

Development stage: Preclinical
Modality: Small Molecules
Administration: Oral, Topical

Overview

Tangzu Fang (糖足方), also known as Tangzu Formula, is a traditional Chinese herbal medicine formula primarily investigated for the treatment of diabetic foot ulcers. It is often administered as granules for oral use or as an ointment for topical application, and is frequently used in conjunction with Western medicine. Research into its mechanism of action suggests it involves multiple chemical components that interact with various signaling pathways, potentially modulating inflammatory responses by affecting cytokines such as Interleukin-6 (IL-6) and Interleukin-1 beta (IL-1β).

Other names: 糖足方Tangzu Formula

Targets

IL-6 (Interleukin 6)IL1B (Interleukin-1 beta)

Beyond the preview

Go deeper on Tangzu Fang.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Tangzu Fang.

Explore the full profile